Interspinous Fusion and Decompression Devices (for Nebraska Only)

Coverage Summary

This Nebraska-specific UnitedHealthcare medical policy (Policy Number: CS363NE.D), effective January 1, 2026, addresses coverage for interspinous fixation (fusion) devices and interspinous/interlaminar decompression or stabilization devices. The policy stance is mixed: interspinous fixation devices used as an adjunct to fusion may be considered medically necessary when performed according to FDA-labeled indications, contraindications, warnings, and precautions and when specified clinical criteria are met; by contrast, interspinous decompression and interlaminar stabilization systems used without fusion are considered unproven and not medically necessary due to insufficient evidence of efficacy. The subject of the policy is Interspinous fixation and decompression devices (Nebraska).

Key thresholds & quick facts

Nonoperative treatment duration6 months

Allowed spondylolisthesisGrade I or less

Allowed scoliosis<= 25°

Functional thresholdsSitting >= 50 minutes; Walk >= 50 feet

Imaging stenosis threshold25-50% reduction in lateral/central foraminal diameter vs adjacent levels

Allowed fusion scopeSingle-level L1-S1

Device context for fusionInterspinous fixation devices used as adjunct with interbody cage for single-level fusion

Medical-Necessity Criteria

Interspinous Fixation (fusion) Devices - Medically Necessary

Interspinous Fixation (fusion) Devices are proven and medically necessary when performed according to FDA labeled indications, contraindications, warnings, and precautions and all of the following criteria are met:

ALL of the following

Back pain of discogenic origin, with degeneration of the disc confirmed by history and radiographic studies
No more than grade 1 spondylolisthesis
Used with an interbody cage as an adjunct to fusion at a single level in the lumbar spine (L1-S1)

FDA labeling requirement: Devices must be performed according to FDA labeled indications, contraindications, warnings, and precautions

Provider Actions & Operational Requirements

Documentation Required

Medical records support medical necessity

The patient's medical record must contain documentation that fully supports the medical necessity for the requested services. This includes a clear and complete clinical history, relevant physical examination findings, and results of pertinent diagnostic tests or procedures that substantiate the diagnosis and need for the device. Records must be legible, maintained in the patient's medical record, and made available to UnitedHealthcare upon request for review. Incomplete, illegible, or missing documentation may result in delay or denial of coverage.

Relevant medical history (symptom duration, prior treatments, prior conservative care and response)
Documented physical examination findings related to the spine
Pertinent diagnostic tests and imaging reports (e.g., radiographs, MRI, CT) supporting degenerative disc disease and level(s) involved
Documentation of grade of spondylolisthesis if present
Operative reports, device implant details, and any intraoperative findings when applicable
Legible entries with dates and author identification; records must be available upon request

Coding

Relevant CPT / Procedure Codes (reference only)CPT

22853	Insertion of interbody biomechanical device(s) with integral anterior instrumentation to intervertebral disc space in conjunction with interbody arthrodesis, each interspace
22854	Insertion of intervertebral biomechanical device(s) with integral anterior instrumentation to vertebral corpectomy defect in conjunction with interbody arthrodesis, each contiguous defect
22859	Insertion of intervertebral biomechanical device(s) to intervertebral disc space or vertebral body defect without interbody arthrodesis, each contiguous defect
22867	Insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, with open decompression, lumbar; single level
22868	Insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, with open decompression, lumbar; second level
22869	Insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, lumbar; single level
22870	Insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, lumbar; second level
22899	Unlisted procedure, spine [when specified as insertion of a non-pedicle interspinous process fixation device]

Definitions & Background

Interspinous devices cover a range of implants: fixation devices that attach to spinous processes to promote stabilization and fusion (interspinous fixation devices), and spacer/distraction devices or interlaminar stabilization devices used to provide indirect decompression or dynamic stabilization. Fixation devices are often proposed as less invasive adjuncts to fusion and may be used with interbody cages; spacers are implanted between spinous processes to distract and decompress neural elements.

The evidence base for standalone interspinous decompression or interlaminar stabilization devices is limited and generally of low quality — comprising systematic reviews, randomized controlled trials of small to moderate size, prospective and retrospective case series, and short- to mid-term follow-up studies. Multiple evidence reviews and technology assessments (ECRI, Hayes) and systematic reviews/meta-analyses summarize inconsistent benefits compared with standard decompression and note methodological limitations, small sample sizes, potential bias, and a need for larger, longer-term RCTs to establish safety and efficacy.

When used as an adjunct to fusion, interspinous fixation devices may be considered in specified contexts and when FDA-labeled and clinical criteria are met; the North American Spine Society (NASS) 2025 guidance supports consideration of interspinous devices affixed to spinous processes when utilized in the context of lumbar fusion with appropriate surgical decortication and grafting techniques.

Risks described in the policy and supporting literature include potential spinous process fracture, focal kyphosis with negative impact on interbody cages or bone grafts, device loosening, and the potential for higher reoperation rates observed in some studies of spacers compared with decompression. These device- and procedure-specific risks underscore the importance of careful patient selection and adherence to labeled indications and documented clinical criteria.

Term	Definition
Arthrodesis	A surgical procedure to eliminate motion in a joint by providing a bony fusion; used for relief of pain, provide stability, overcome postural deformity, and to halt advancing disease.
Interlaminar Lumbar Instrumented Fusion (ILIF)	During the ILIF procedure, the surgeon makes an incision in the lower back and an opening is created through the ligaments to access the spinous processes; bone, ligament or disc causing compression is removed, allograft or autologous bone may be placed, and an implant is inserted to stabilize and secure the spinous processes until fusion takes place.
Interlaminar Stabilization Device	An implantable interspinous process device intended to provide symptomatic relief of claudicatory lumbar spinal stenosis by reducing lumbar extension while preserving range of motion in flexion, axial rotation, and lateral bending; typically inserted horizontally between adjacent spinous processes and crimped over bone after decompression of stenosis.
Interspinous Fixation Devices	Devices intended for attachment to the spinous processes to achieve stabilization to promote fusion in patients with degenerative disc disease.
Interspinous Process Decompression (IPD)	Minimally invasive procedure implanting a spacer between affected spinous processes to distract and decompress nerves; spacers provide dynamic stabilization following decompressive surgery and are intended to block stenosis-related lumbar extension.
Lumbar Spinal Stenosis (LSS)	Narrowing or constriction of the lumbar spinal canal that may result in painful compression of a nerve and/or blood vessel(s) supplying the nerve.
Neurogenic Claudication	Indicator of LSS characterized by pain or weakness in buttock, thigh, or leg that is relieved by a change in position or leaning forward and improves with rest; should be differentiated from vascular claudication.
Arthrodesis (updated)	Definition updated (text not included in excerpt).
Interlaminar Lumbar Instrumented Fusion (ILIF) (updated)	Definition updated (text not included in excerpt).
Interlaminar Stabilization Device (updated)	Definition updated (text not included in excerpt).
Neurogenic Claudication (updated)	Definition updated (text not included in excerpt).

Evidence & Guideline Context

The clinical evidence cited in the policy includes: systematic reviews and meta-analyses, randomized controlled trials (RCTs), prospective and retrospective case series, and technology assessments (e.g., ECRI, Hayes).

Systematic reviews and meta-analyses report mixed results: some analyses find short-term improvements in pain or function with interspinous/interlaminar devices versus decompression at selected time points, while others show no significant differences in primary outcomes; overall quality of evidence is often rated low or insufficient.

Randomized trials and prospective studies cited are typically small to moderate in size and limited by short- to mid-term follow-up, risk of bias, and heterogeneity in devices and surgical techniques; several assessments call for larger, well-designed long-term RCTs to establish comparative safety and efficacy.

The North American Spine Society (NASS) 2025 guidance is incorporated as contextual guidance: it supports use of interspinous devices affixed to spinous processes when used as an adjunct to lumbar fusion under specified surgical and patient-selection conditions, and it defines qualifying criteria and exclusions for static interspinous distraction devices used without fusion.

Evidence summary

Study types citedSystematic reviews, RCTs, prospective and retrospective case series

Quality of evidence (decompression devices without fusion)

Medical Records Documentation for Reviews

Medical records documentation for reviews

Covered when ALL of the following are met:

Documentation requirements: The patient's medical record must contain documentation that fully supports the medical necessity for the requested services

Required content: Documentation includes but is not limited to relevant medical history, physical examination, and results of pertinent diagnostic tests or procedures

Operational requirement for audits/reviews: Documentation supporting the medical necessity should be legible, maintained in the patient's medical record, and must be made available upon request

Revision History

01/01/2026revisedLatest

Medical Records Documentation Used for Reviews section updated to require explicit documentation supporting medical necessity and to add language about legibility and availability upon request.

01/01/2026updated

Definitions for Arthrodesis, Interlaminar Lumbar Instrumented Fusion (ILIF), Interlaminar Stabilization Device, and Neurogenic Claudication were updated.

01/01/2026updated

NASS 2025 Recommendations (contextual coverage guidance cited)

North American Spine Society guidance incorporated in supporting information; used as context for indications and contraindications when considering interspinous devices with fusion or static interspinous distraction devices without fusion.

ALL of the following

When interspinous devices affixed to spinous processes may be considered (with fusion adjunct)
- Utilized in context of lumbar fusion for diagnoses including stenosis, disc herniations, or synovial facet cysts
- Adjunct to cyst excision when >50% of the facet joint is removed
- Utilized with robust open laminar and/or facet decortication and fusion and/or robust autograft inter- and extra-spinous process decortication and fusion and/or an interbody fusion of same motion segment
Scenarios where interspinous fixation devices should not be utilized
- Spondylolisthesis greater than Grade I
- Bilateral isthmic spondylolysis
- Significant dynamic instability (e.g., on flexion-extension views)
- Scoliosis, or signs of coronal or rotatory instability
- Fusion indicated at more than one lumbar level
- Generally not indicated for L5-S1 due to mechanical limitations of S1 spinous process (unless anatomy favorable)
- Complete resection of the facet (unless accompanied by an interbody fusion)
- Disc herniations: not indicated except as adjunct to primary excision in absence of instability or spondylolisthesis
- Stenosis: not indicated except as adjunct to primary decompression in absence of instability, foraminal stenosis, spondylolisthesis
- Discogenic low back pain
- A fusion is otherwise not indicated per NASS Coverage Recommendation for Lumbar Fusion
Static interspinous distraction devices (NASS 2025 qualifying criteria)
- Clinically symptomatic degenerative lumbar stenosis associated with neurogenic claudication relieved by lumbar flexion
- Sitting for at least 50 minutes without pain
- Can walk at least 50 feet
- Mild to moderate stenosis on CT/MRI defined as 25-50% reduction in lateral/central foraminal diameter compared to adjacent levels
- Failure of 6 months nonoperative treatment
- No more than 25° of degenerative scoliosis
Static device exclusions per NASS
- Degenerative spondylolisthesis Grade II or higher
- Degenerative scoliosis >25°
- Dynamic instability at operative level
- Symptoms not relieved by flexion
- Patient medically suitable for direct decompressive procedure
- Patient has primarily axial back pain unrelated to activity